Genentech Receives US Subpoena in Rituxan Marketing Probe Genentech Inc., the world #39;s second- biggest biotechnology company, received a subpoena from the US Attorney #39;s office in Philadelphia as part of a criminal and civil investigation into marketing of its top-selling drug, Rituxan.